Pastille made from a black maca composition

Abstract

Pastille of a black maca composition (Z), comprising: - a pastille core (1) containing a black maca component and a Turnera diffusa extract; and - an outer film coating layer (2) which surrounds the pastille core (1) from the outside.

Description

[0001] The present invention relates to a pastille, in particular a pastille containing a black maca composition.

[0002] Over time, the pace of modern life is gradually developing into a hectic trend. In modern times, enormous psychological pressure and poor lifestyle and dietary habits have placed a heavy burden on the body and had many negative effects on the normal physiological functions of the human body. As a result, nutraceuticals have been developed to quickly supply the body with nutrients and vitamins.

[0003] In modern times, humanity has discovered a plant with great nutritional value: maca (Lepidium meyenii). Also known as Inca radish or Peruvian ginseng, maca root is rich in nutrients such as proteins, carbohydrates, fatty acids, amino acids, minerals, vitamins, and special compounds unique to maca: macaenes and macaamides. Maca is therefore an excellent source of nutritional supplements and can contribute to the regulation of the human body's physiological functions. Depending on its color, maca can be divided into yellow maca, red maca, and black maca, with black maca being the least produced and having the highest nutritional value.

[0004] Furthermore, Turnera diffusa and Amaranthus gangeticus L. are plants that have been proven in modern times to be rich in phytonutrients. Turnera diffusa is rich in natural active ingredients such as polyphenolic compounds, flavonoids, terpenoids, and cyanogenic glycosides, which can help increase physical strength and promote metabolism, as well as alleviate depression and increase mental satisfaction. Amaranthus gangeticus L., on the other hand, is rich in iron, calcium, and vitamin C and can promote vasodilation, thus improving blood circulation and athletic performance, which in turn boosts cardiovascular and sexual function and promotes bone health and immunity.

[0005] Therefore, there is still a need for an improved pastille structure that combines the nutrients of black maca, Turnera diffusa extract, and Amaranthus gangeticus L. extract in high concentration to increase the richness of health-promoting ingredients and the health effects of the respective healthy food.

[0006] Based on the disadvantages of the prior art, the present invention aims to offer a pastille of a black maca composition having a high concentration and content of black maca, Turnera diffusa extract and Amaranthus gangeticus L. extract, which can help regulate the user's physiological functions, improve the body's health and relieve mental stress.

[0007] To achieve this objective, the present invention proposes a lozenge made from a black maca composition, comprising a lozenge core and an outer film coating layer. The lozenge core contains a black maca component and a Turnera diffusa extract. The outer film coating layer encloses the lozenge core from the outside.

[0008] In one embodiment of the present invention, the outer film coating layer completely envelops the outer surface of the lozenge core.

[0009] In one embodiment of the present invention, with a total amount of the pastille made from a black maca composition of 1290 mg, the amount of the black maca component is between 800 mg and 850 mg.

[0010] In one embodiment of the present invention, the black maca component is black maca powder.

[0011] In one embodiment of the present invention, with a total amount of the pastille made from a black maca composition of 1290 mg, the amount of Turnera diffusa extract is between 100 mg and 160 mg.

[0012] In one embodiment of the present invention, the pastille core further contains an Amaranthus gangeticus L. extract, the amount of which is between 60 mg and 100 mg for a total amount of the pastille consisting of a black maca composition of 1290 mg.

[0013] In one embodiment of the present invention, the pastille core contains at least one excipient.

[0014] In one embodiment of the present invention, the excipient comprises polyvinylpyrrolidone and corn starch.

[0015] In one embodiment of the present invention, the base body of the pastille further contains a functional ingredient selected from a group consisting of vitamin B1, vitamin B2, vitamin B6, vitamin B12 and a zinc component.

[0016] In one embodiment of the present invention, the weight of the lozenge of a black maca composition is between 1000 mg and 1600 mg.

[0017] In one embodiment of the present invention, the black maca composition pastille has a three-dimensional shape in the form of a circular cylinder, an elongated bar, or a square cylinder.

[0018] In summary, the black maca composition pastille according to the present invention can provide a black maca composition pastille enriched with a high concentration and high content of black maca, Turnera diffusa extract, and Amaranthus gangeticus L. extract through the technical solution comprising a combination of the technical features of “a pastille core containing a black maca component and a Turnera diffusa extract” and “an outer film coating layer externally enveloping the pastille core.”

[0019] For a better understanding of the features and technical content of the present invention, reference is made to the following detailed description and the drawings of the present invention, which, however, are for illustrative purposes only and are not intended to limit the scope of the present invention. Fig. Figure 1 shows a three-dimensional schematic representation of an embodiment of a pastille of a black maca composition of the present invention and Fig. Figure 2 shows a schematic sectional view of a pastille of a black maca composition of the present invention along the section line II-II in Fig. 1.

[0020] In the following, the embodiments of a pastille made from a black maca composition disclosed within the scope of the present invention are described using specific concrete exemplary embodiments. Those skilled in the art will appreciate that advantages and technical effects of the present invention can be derived from the disclosures in the present description. The present invention can be implemented or applied through other concrete exemplary embodiments, and various modifications or changes can be made to the details disclosed in the present description as needed and for specific applications, without thereby departing from the basic ideas of the present invention. Furthermore, it should be noted that the individual components of the present invention are not shown in their actual size, but only schematically.The following embodiments serve to further describe the embodiments of the present invention in more detail, but the corresponding disclosures do not represent a limitation on the scope of the present invention.

[0021] Unless otherwise defined, the terms used herein have the same meaning as commonly understood by those skilled in the art. Materials used in the embodiments are commercially available or manufactured according to the prior art, unless otherwise noted. Methods or processes employed in the embodiments are, unless specifically stated otherwise, conventional methods or processes in the art. [Examples of implementation]

[0022] It is based on the Fig. 1 and Fig. 2, which respectively show a three-dimensional schematic representation and a schematic sectional representation of an embodiment of a pastille made from a black maca composition Z of the present invention. The pastille made from a black maca composition Z comprises a pastille core 1 and an outer film coating layer 2, wherein the outer film coating layer 2 encloses the pastille core 1 from the outside.

[0023] The pastille core 1 contains a main active ingredient 11, which includes a combination of black maca component, Turnera diffusa extract, and Amaranthus gangeticus L. extract, and can be evenly distributed within the pastille core 1. In certain embodiments, the black maca component in the pastille core 1 is black maca powder or black maca extract obtained from 90% to 100% high-purity black maca concentrated by a factor of 6, and which can contain nutrients such as vitamin C, vitamin K, vitamin B complex, and calcium, and is produced in the pastille core 1 through a special gelling process, which is more favorable for absorption by the human body and can improve utilization efficiency in the human body.Turnera diffusa extract is an 18-fold concentrated Turnera diffusa extract from Spain, containing natural active ingredients such as polyphenolic compounds, flavonoids, terpenoids, and cyanogenic glycosides. These highly concentrated nutrients can improve the user's endurance and stimulate metabolism, which can help regulate physical and physiological functions and have a positive effect on mental stress relief. Amaranthus gangeticus L. extract is extracted from the natural Amaranthus gangeticus L. in India and extracted and concentrated through a special water extraction technology to produce a 50-fold concentrated Amaranthus gangeticus L. extract in the lozenge core. This doubles the concentration of nitric oxide in the Amaranthus gangeticus L. extract, which has a profound effect and helps improve the reproductive function of the human body.

[0024] In certain embodiments, for a total amount of the pastille from a black maca composition Z of 1290 mg, the amount of the black maca component is between 800 mg and 850 mg, the amount of the Turnera diffusa extract is between 100 mg and 160 mg, and the amount of the Amaranthus gangeticus L. extract is between 60 mg and 100 mg.

[0025] In certain embodiments, the lozenge core 1 further contains a functional ingredient 12. The functional ingredient 12 can be selected from a group consisting of vitamin B1, vitamin B2, vitamin B6, vitamin B12, and a zinc component. The vitamin B complex and zinc can contribute to the regulation of physiological functions, with vitamin B2 contributing to the maintenance of normal energy metabolism in the human body, vitamin B6 promoting nervous system health, and vitamin B12 contributing to the maintenance of reproductive functions.In certain embodiments, with a total amount of the pastille made from a black maca composition Z of 1290 mg, the amount of vitamin B1 is between 0.3 mg and 0.6 mg, the amount of vitamin B2 is between 0.4 mg and 0.7 mg, the amount of vitamin B6 is between 0.4 mg and 0.7 mg, the amount of vitamin B12 is between 0.6 µg and 1.0 µg, and the amount of the zinc component is between 2.9 mg and 4.4 mg. Furthermore, in certain embodiments, the zinc component is contained in the pastille core 1 in the form of zinc gluconate.

[0026] Thus, the functional ingredient 12 can supplement the lozenge core 1 with the amount of nutrients contained in the main active ingredient 11 itself and replenish it with the nutrients not contained in the main active ingredient 11, so that the lozenge core 1 is enriched with a variety of nutrients and can provide the user with a high concentration and purity of rich nutrients.

[0027] Furthermore, in certain embodiments, the pastille core 1 may additionally contain an excipient such as polyvinylpyrrolidone (used as a binder to bind the main active ingredient 11 to the functional ingredient 12 for pastille formation), corn starch (to increase the volume of the pastille to ensure a precise amount), magnesium stearate (to reduce friction during bar formation or pastille pressing), silicon dioxide (used as a flow aid to improve the flowability of the powder of the main active ingredient 11 and the functional ingredient 12 and to ensure uniform distribution of the powdered component in the pastille core 1), and the like.

[0028] The above-mentioned main active ingredient 11, the functional ingredient 12, and the excipient can be prepared in any suitable form, e.g., as solid particles or powder, liquid, paste, etc., and formed into a solid lozenge core 1 having a specific three-dimensional shape by mixing and homogenizing, molding, and drying. The lozenge core 1 can have any suitable three-dimensional shape, which is not limited by the present invention.

[0029] The outer film coating layer 2 encloses the lozenge core 1 from the outside and can be created by spraying a film coating material onto the lozenge core 1 and drying it. In certain embodiments, the outer film coating layer 2 completely encloses the lozenge core 1 from the outside. In certain embodiments, the material of the outer film coating layer 2 can be selected from a group consisting of hydroxypropylmethylcellulose, hydroxypropylcellulose, and polyethylene glycol. The outer film coating layer 2 can help maintain the finished shape of the lozenge core 1 and prevent the lozenge core 1 from breaking during transport.The outer film coating layer 2 can also impart smooth surface properties to the black maca compound Z lozenge, which can prevent excessive friction of the lozenge against the user's throat and reduce the user's discomfort when swallowing the lozenge, while preventing the lozenge core 1 from decomposing in the mouth and producing a bitter taste. Furthermore, the film coating material of the outer film coating layer 2 can be selected to be degraded in a specific organ (e.g., the intestine), so that the lozenge core 1 is degraded and digested to release its internal components only after it reaches the organ with better absorption performance.

[0030] In certain embodiments, the pastille of a black maca composition Z may also have a different three-dimensional shape than that shown in Fig.1, such as the shape of a circular cylinder, an elongated bar, or a square cylinder, which is not limited by the present invention. In certain embodiments, the weight of the lozenge of a black maca composition Z is between 1000 mg and 1600 mg. [Advantageous effects of the embodiments]

[0031] The black maca composition pastille according to the present invention can provide a black maca composition pastille enriched with a high concentration and high content of black maca, Turnera diffusa extract, and Amaranthus gangeticus L. extract through the technical solution comprising a combination of the technical features of “a pastille core containing a black maca component and a Turnera diffusa extract” and “an outer film coating layer externally enveloping the pastille core.”

[0032] Compared with conventional maca pastilles, the black maca compound pastille of the present invention combines the highly concentrated nutrients of black maca, Turnera diffusa extract, and Amaranthus gangeticus L. extract in a composite form, providing a rich source of nutritional supplementation for the user. Thus, the user can obtain the nutrients previously obtained from a variety of nutritional supplements from a single black maca compound pastille of the present invention. In addition, the black maca compound pastille of the present invention offers excellent maintenance effects, such as regulating the user's physiological functions, increasing physical strength and vitality, and promoting the user's physical and mental health.

[0033] The above disclosure merely represents preferred possible embodiments of the present invention and is not intended to limit the scope of the claims of the present invention, so that all equivalent technical changes made by applying the contents of the description and the drawings of the present invention fall within the scope of the claims of the present invention. List of reference symbols 1 lozenge core 11 Main active ingredient 12 Functional ingredient 2 Outer film coating layer II-II section line Z Pastille made from a black maca composition

Claims

[1] Pastille of a black maca composition (Z), comprising: - a pastille core (1) containing a black maca component and a Turnera diffusa extract; and - an outer film coating layer (2) which surrounds the pastille core (1) from the outside. [2] A pastille of a black maca composition (Z) according to claim 1, wherein the outer film coating layer (2) completely envelops the outer surface of the pastille core (1). [3] A pastille of a black maca composition (Z) according to claim 1 or 2, wherein, with a total amount of the pastille of a black maca composition (Z) of 1290 mg, the amount of the black maca component is between 800 mg and 850 mg. [4] A pastille of a black maca composition (Z) according to any one of claims 1 to 3, wherein the black maca component is black maca powder. [5] A pastille of a black maca composition (Z) according to any one of claims 1 to 4, wherein, with a total amount of the pastille of a black maca composition (Z) of 1290 mg, the amount of Turnera diffusa extract is between 100 mg and 160 mg. [6] A pastille of a black maca composition (Z) according to any one of claims 1 to 5, wherein the pastille core (1) further contains an Amaranthus gangeticus L. extract, the amount of which is between 60 mg and 100 mg for a total amount of the pastille of a black maca composition (Z) of 1290 mg. [7] Pastille of a black maca composition (Z) according to any one of claims 1 to 6, wherein the pastille core (1) contains at least one excipient. [8] A pastille of a black maca composition (Z) according to claim 7, wherein the excipient comprises polyvinylpyrrolidone and corn starch. [9] A pastille of a black maca composition (Z) according to any one of claims 1 to 8, wherein the pastille core (1) further contains a functional ingredient (12) selected from a group consisting of vitamin B1, vitamin B2, vitamin B6, vitamin B12 and a zinc component. [10] A pastille of a black maca composition (Z) according to any one of claims 1 to 9, wherein the weight of the pastille of a black maca composition (Z) is between 1000 mg and 1600 mg. [11] A pastille of a black maca composition (Z) according to any one of claims 1 to 10, wherein the pastille of a black maca composition (Z) has a three-dimensional shape in the form of a circular cylinder, an elongated bar or a square cylinder.

Images